公司資料
Alcon Inc. 股價、新聞與催化劑
- 股票代碼:
- ALC
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- Switzerland and listed in the U
股票表現
63.76 USD (-0.28%)
收盤價
最後更新: 2026年10月2日
31.3B USD
市值
股價為何變動
截至 2026年10月2日，ALC 下跌 0.28%，收於 $63.76。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Global Eye Care Company
Alcon is a global eye care company with surgical and vision-care products used in more than 140 countries and territories. Its portfolio addresses cataracts, refractive errors, glaucoma, retinal disease, contact-lens needs, and ocular surface conditions.
Surgical Equipment and Consumables
The Surgical segment provides cataract and vitreoretinal systems, intraocular lenses, visualization technologies, surgical packs, and related consumables. Installed equipment supports recurring demand for procedure-specific products and service.
Intraocular Lens Portfolio
Alcon offers monofocal, toric, and presbyopia-correcting intraocular lenses for cataract surgery. Premium lenses and delivery systems are designed to improve visual outcomes while expanding the range of vision correction available to surgeons and patients.
Vision Care Franchise
Vision Care includes daily and reusable contact lenses, lens-care solutions, and ocular health products. Brands and product platforms span silicone hydrogel lenses, multifocal and toric designs, dry-eye care, and consumer lens maintenance.
Digital and Refractive Technologies
Alcon is building connected cataract workflows through its Adi digital ecosystem and maintains a large refractive-surgery portfolio through WaveLight. Partnerships in adjustable lenses and other optical technologies extend the company's innovation beyond its current product base.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。